Australia Expands Psychedelic Therapy Access

Australia just took a bold step forward in psychedelic therapy, becoming the first country to officially permit MDMA for PTSD and psilocybin for treatment-resistant depression. New regulations loosen strict requirements—psychologists are no longer mandatory, and doctors can leave after administering the drug. While advocates celebrate this as a path to more affordable, accessible care, mental health professionals warn about safety risks without clear training standards for support staff. These drugs remain unapproved for general use, untested for quality, efficacy, or safety. The balance between expanding access and protecting patients remains the key challenge as this rapidly evolving field continues to unfold. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/215031a2e62fff15